Kala Pharmaceuticals to Present at BofA Securities 2021 Healthcare Conference

Rhea-AI Summary

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company specializing in innovative eye disease therapies, will present at the BofA Securities 2021 Healthcare Conference. The management team is set to participate in a Fireside Chat on May 13, 2021, at 4:15 pm ET. Investors can access the live webcast and a recording afterward via the 'Events' section of the Kala website. The company's products include EYSUVIS® and INVELTYS®, which utilize AMPPLIFY® technology, addressing dry eye disease and post-operative inflammation.

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will present at the BofA Securities 2021 Healthcare Conference. Management is scheduled to participate in a Fireside Chat on Thursday, May 13, 2021 at 4:15 pm ET.

To access the webcast and subsequent archived recording of the presentation, please visit “Events” in the “Investors” section of the Kala website at http://kalarx.com

About Kala Pharmaceuticals, Inc.
Kala is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for diseases of the eye. Kala has applied its AMPPLIFY^® mucus-penetrating particle (MPP) Drug Delivery Technology to two ocular therapies, EYSUVIS^® (loteprednol etabonate ophthalmic suspension) 0.25% for the short-term (up to two weeks) treatment of signs and symptoms of dry eye disease and INVELTYS^® (loteprednol etabonate ophthalmic suspension) 1% for the treatment of post-operative inflammation and pain following ocular surgery. The Company also has a pipeline of preclinical development programs targeted to address unmet medical needs, including both front and back of the eye diseases. For more information on Kala, please visit www.kalarx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210506005023/en/

FAQ

When is Kala Pharmaceuticals presenting at the 2021 Healthcare Conference?

Kala Pharmaceuticals will present at the BofA Securities 2021 Healthcare Conference on May 13, 2021, at 4:15 pm ET.

How can I access the presentation by Kala Pharmaceuticals?

The presentation can be accessed through the 'Events' section of the Kala Pharmaceuticals website.

What products does Kala Pharmaceuticals offer?

Kala Pharmaceuticals offers EYSUVIS® for dry eye disease and INVELTYS® for post-operative inflammation and pain.

What technology does Kala Pharmaceuticals utilize in its products?

Kala Pharmaceuticals utilizes AMPPLIFY® mucus-penetrating particle (MPP) Drug Delivery Technology in its ocular therapies.

Where can I find more information about Kala Pharmaceuticals?

More information about Kala Pharmaceuticals can be found on their official website at www.kalarx.com.